Beta-adrenergic Blocking Agents and Dental Vasoconstrictors

Dental Clinics of North America

Volumn 54, Issue 4, 2010, Pages 687-696

  Hersh, Elliot V ^a,b   Giannakopoulos, Helen ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beta adrenergic blocking agents; Dental vasoconstrictors; Epinephrine; Levonordefrin; Metoprolol; Propranolol

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORBADRINE; LOCAL ANESTHETIC AGENT; METOPROLOL; PROPRANOLOL; VASOCONSTRICTOR AGENT;

BRADYCARDIA; CHEMICALLY INDUCED DISORDER; DENTAL ANESTHESIA; DRUG INTERACTION; HUMAN; HYPERTENSION; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANESTHESIA, DENTAL; ANESTHETICS, LOCAL; BRADYCARDIA; DRUG INTERACTIONS; EPINEPHRINE; HUMANS; HYPERTENSION; METOPROLOL; NORDEFRIN; PROPRANOLOL; VASOCONSTRICTOR AGENTS;

EID: 77956433955     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2010.06.009     Document Type: Review

References (26)

1. Jastak J.T., Yagiela J.A. Vasoconstrictors and local anesthesia: a review and rationale for use. J Am Dent Assoc 1983, 107(4):623-629.
2. Cassidy J.P., Phero J.C., Grau W.H. Epinephrine: systemic effects and varying concentrations of local anesthesia. Anesth Prog 1986, 33(6):289-297.
3. Goulet J.P., Pérusse R., Turcotte J.Y. Contraindications to vasoconstrictors in dentistry: part III. Pharmacologic interactions. Oral Surg Oral Med Oral Pathol 1992, 74(5):692-697.
4. Hersh E.V. Local anesthetics in dentistry: clinical considerations, drug interactions, and novel formulations. Compend Contin Educ Dent 1993, 14(8):1020-1028.
5. Yagiela J.A. Vasoconstrictors agents for local anesthesia. Anesth Prog 1995, 42(3-4):116-120.
6. Yagiela J.A. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors. J Am Dent Assoc 1999, 130(5):701-709.
7. Brown R.S., Rhodus N.L. Epinephrine and local anesthesia revisited. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100(4):401-408.
8. Hersh E.V., Moore P.A. Adverse drug interactions in dentistry. Periodontol 2000 2008, 46:109-142.
9. Foster C.A., Aston S.J. Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg 1983, 72(1):74-78.
10. Houben H., Thien T., van't Laar A. Effect of low-dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension. Clin Pharmacol Ther 1982, 31(6):685-690.
11. Mackie K., Lam A. Epinephrine-containing test dose during beta-blockade. J Clin Monit 1991, 7(3):213-216.
12. Hjemdahl P., Akerstedt T., Pollare T., et al. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl 1983, 515:45-53.
13. Rehling M., Svendsen T.L., Maltbaek N., et al. Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man. Eur J Clin Pharmacol 1986, 30(6):659-663.
14. Sugimura M., Hirota Y., Shibutani T., et al. An echocardiographic study of interactions between pindolol and epinephrine contained in a local anesthetic solution. Anesth Prog 1995, 42(2):29-35.
15. Niwa H., Sugimura M., Satoh Y., et al. Cardiovascular response to epinephrine-containing local anesthesia in patients with cardiovascular disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 92(6):610-616.
16. Boakes A.J., Laurence D.R., Lovel K.W., et al. Adverse reactions to local anesthetic/vasoconstrictor preparations. A study of the cardiovascular responses to xylestesin and hostacain-with-noradrenaline. Br Dent J 1972, 133(4):137-140.
17. van der Bijl P., Victor A.M. Adverse reactions associated with norepinephrine in dental local anesthesia. Anesth Prog 1992, 39(3):87-89.
18. Barnard D.P., Joubert P.H., Venter C.P. Noradrenaline and local anaesthesia: a review of the literature and a clinical evaluation. J Dent Assoc S Afr 1987, 42(4):185-191.
19. Jastak J.T., Yagiela J.A., Donaldson D. Pharmacology of vasoconstrictors. Local anesthesia of the oral cavity 1995, 61-85. WB Saunders, Philadelphia.
20. Hersh E.V., Giannakopoulos H., Levin L.M., et al. The pharmacokinetics and cardiovascular effects of high-dose articaine with 1:100,000 and 1:200,000 epinephrine. J Am Dent Assoc 2006, 137(11):1562-1571.
21. Yagiela J.A. Death in a cardiac patient after local anesthesia with epinephrine. Orofac Pain Manage 1991, 1:6.
22. Campbell J.H., Huizinga P.J., Das S.K., et al. Incidence and significance of cardiac arrhythmia in geriatric oral surgery patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82(1):42-46.
23. Piacik M.T., Abel P.W. Adrenergic blocking drugs. Pharmacology and therapeutics for dentistry 2004, 113-124. Elsevier Mosby, St Louis (MO). 5th edition. J.A. Yagiela, F.J. Dowd, E.A. Neidle (Eds.).
24. Naftalin L.W., Yagiela J.A. Vasoconstrictors: indications and precautions. Dent Clin North Am 2002, 46(4):733-746.
25. Mito R.S., Yagiela J.A. Hypertensive response to levonordefrin in a patient receiving propranolol: report of case. J Am Dent Assoc 1988, 116(1):55-57.
26. Kellam S.A., Smit J.R., Scheffel S.J. Epinephrine absorption from commercial gingival retraction cords in clinical patients. J Prosthet Dent 1992, 68(5):761-765.